Macrocyclic Polypeptides with L/D Amino Acids

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current approaches to designing macrocyclic peptides are limited by the difficulty in systematically searching the structural space spanned by such compounds, as natural proteins do not provide useful guides for regular secondary structures and hydrophobic cores, and existing methods struggle to repurpose macrocycles for new functions.

Innovation Solution

The development of macrocyclic polypeptides comprising up to 3 amino acid substitutions compared to a reference sequence, incorporating both L and D amino acids, which are designed to fold into stable structures through near exhaustive backbone sampling and energy landscape calculations, enabling the identification of over 200 designs that can serve as starting points for therapeutics.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If natural proteins are used as guides for macrocycle design, then the design process is simplified, but natural proteins do not provide useful guides for regular secondary structures and hydrophobic cores

Engineering Contradiction:
Improveease of macrocycle designVSAvoidstructural diversity of macrocycles
Core Design Contradiction:
Ease of manufactureVSAdaptability or versatility

Solution Approach 1:

The patent changes the fundamental parameters of amino acid chirality by incorporating both L and D amino acids in specific patterns, enabling the formation of regular secondary structures and hydrophobic cores that are not accessible with natural L-amino acids alone. This parameter change allows systematic exploration of macrocycle structural space while maintaining designability.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates composite macrocyclic structures by combining L and D amino acid residues in defined sequences, producing hybrid structures that exhibit both regular secondary structures and hydrophobic cores. These composite structures overcome the limitations of natural proteins as design guides while expanding structural versatility.

Inventive Principle:
Principle #40Composite materials

2Adaptability or versatility

If random library selection methods are used, then a wide range of sequences can be explored, but only a small fraction of the vast sequence space is covered and peptides are not structured in the absence of target

Engineering Contradiction:
Improvesequence space coverageVSAvoidstructural stability of peptides
Core Design Contradiction:
Adaptability or versatilityVSStability of the object's composition

Solution Approach 1:

The patent applies preliminary structural design by calculating energy landscapes and identifying low-energy conformations before target binding. This preliminary action ensures that macrocycles are pre-structured with regular secondary structures and hydrophobic cores, enabling them to maintain stability in the absence of target while still exploring diverse sequence space through systematic L/D amino acid combinations.

Inventive Principle:
Principle #10Preliminary action

3Stability of the object's composition

If few amino acid substitutions are allowed compared to reference sequences, then the design process is constrained, but this limitation enables identification of stable folded structures

Engineering Contradiction:
Improvestructural stability of macrocyclesVSAvoiddiversity of macrocycle structures
Core Design Contradiction:
Stability of the object's compositionVSAdaptability or versatility

Solution Approach 1:

The patent introduces asymmetry through the strategic placement of D-amino acid residues alongside L-amino acids, creating chiral patterns that stabilize specific folded structures. This asymmetric design allows constrained substitution (maintaining stability) while generating diverse macrocycle structures through different L/D arrangement patterns in the sequence.

Inventive Principle:
Principle #4Asymmetry

Data Source

PatentUS11524979B2Macrocyclic polypeptides
Publication Date: 2022.12.13 UNIV OF WASHINGTON
  • US11524979B2 patent drawing
  • US11524979B2 patent drawing

AI summary

Disclosed herein are macrocyclic polypeptides having no more than 3 ammo acid substitutions compared to the amino acid sequence of any one of SEQ ID NO: 1-2.37 or a mirror image thereof, wherein the polypeptide includes both L and D amino acids, libraries of such polypeptides, and uses thereof.